Step‐down and move forward-Reference-Cited by-同舟云学术

Step‐down and move forward

Published:2020-05-08 Issue:7 Volume:67 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Simon Arne¹^ORCID,Lehrnbecher Thomas²^ORCID,Groll Andreas H.³,Laws Hans‐Jürgen⁴,Ammann Roland A.⁵

Affiliation:

1. Pediatric Oncology and Hematology Children's Hospital Medical Center University Clinics Homburg Germany

2. Division for Pediatric Hematology and Oncology Hospital for Children and Adolescents University Hospital Goethe University Frankfurt am Main Frankfurt Germany

3. Department of Pediatric Hematology and Oncology University Children's Hospital Muenster Muenster Germany

4. Department of Pediatric Oncology Hematology and Clinical Immunology University of Duesseldorf Duesseldorf Germany

5. Pediatric Hematology/Oncology Department of Pediatrics Inselspital Bern University Hospital University of Bern Bern Switzerland

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.28342

Reference13 articles.

1. Safety and efficacy of step‐down to oral outpatient treatment versus inpatient antimicrobial treatment in pediatric cancer patients with febrile neutropenia: a noninferiority multicenter randomized clinical trial;Aviles‐Robles MJ;Pediatr Blood Cancer,2020

2. Advances in management of low-risk febrile neutropenia

3. The Use of Cefepime for Treating AmpC β-Lactamase–Producing Enterobacteriaceae

4. Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli

5. Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Bacteremia in Febrile Neutropenic Children